The Potential of Moringa Leaf Nanoparticles (Moringa oleifera) on the Expression of TNFα, IL10, and HSP 27 in Oral Cavity Cancer

Authors

DOI:

https://doi.org/10.47352/jmans.2774-3047.198

Keywords:

nanoparticle, Moringa oleifera, oral cancer, TNF-α, HSP27, IL-10, immunology

Abstract

Oral cancer is currently the sixth leading malignancy in the world, with over 330,000 cases resulting in death. Several cytokines and proteins protect the survival of cancer cells, such as TNF-α, HSP27, and IL-10. Moringa oleifera is an herbal medicine with anti-cancer properties. Nanoparticles of M. oleifera have the property to be easily absorbed by water-soluble cells, so only small doses are needed to be used as anti-cancer ingredients. This research aims to prove the ability of M. oleifera nanoparticle extract against oral cancer through the expression of tumour necrosis factor α (TNF-α), heat shock protein (HSP27), and interleukin 10 (IL-10). Rat as non-human experimental subjects were divided into four groups: control group (K), treatment group 1 (P1), treatment group 2 (P2), and treatment group 3 (P3). Cancer induction was carried out by injecting with benzo[a]pyrene, and then M. oleifera nanoparticle extract was administered in three forms of treatment doses of 125 μg/mL (P1), 250 μg/mL (P2), and 500 μg/mL (P3). Immunohistochemical examination was analysed through TNF-α, HSP27, and IL-10’s expression. The expression of TNF-α and HSP27 between control and treatment groups was significantly different. P2 had the lowest expression of TNF-α and HSP27. The expression of IL-10 between control and treatment groups was also significantly different. P1 had the lowest expression of IL-10. M. oleifera nanoparticle extract can reduce oral cancer progression by decreasing the expression of TNF-α, HSP27, and IL-10.

References

[1] H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray. (2021). "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries". CA: A Cancer Journal for Clinicians. 71 (3): 209-249. 10.3322/caac.21660.

[2] I. Teneng, D. E. Montoya-Durango, J. L. Quertermous, M. E. Lacy, and K. S. Ramos. (2011). "Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation". Epigenetics. 6 (3): 355-67. 10.4161/epi.6.3.14282.

[3] D. Musiani, J. D. Konda, S. Pavan, E. Torchiaro, F. Sassi, A. Noghero, J. Erriquez, T. Perera, M. Olivero, and M. F. Di Renzo. (2014). "Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy". The FASEB Journal. 28 (9): 4055-67. 10.1096/fj.13-247924.

[4] T. I. Budhy.(2019)." Why Cancer Happens". Airlangga University Press, Surabaya.

[5] A. Abirami, S. M. Halith, and K. K. Pillai. (2014). "Herbal Nanoparticle for Anticancer Potential- a Review". World Journal of Pharmacy and Pharmaceutical Sciences. 3 (8): 2123-2132.

[6] E. Alphandery. (2022). "Ultrasound and nanomaterial: an efficient pair to fight cancer". Journal of Nanobiotechnology. 20 (1): 139. 10.1186/s12951-022-01243-w.

[7] V. Jadhav, A. Bhagare, I. H. Ali, A. Dhayagude, D. Lokhande, J. Aher, M. Jameel, M. Dutta, and A. Roy. (2022). "Role of Moringa oleifera on Green Synthesis of Metal/Metal Oxide Nanomaterials". Journal of Nanomaterials.2022 : 1-10. 10.1155/2022/2147393.

[8] M. Muhaimin, A. Y. Chaerunisaa, T. Rostinawati, E. R. I. Amalia, A. Hazrina, and S. Nurhasanah. (2023). "A Review on Nanoparticles of Moringa Oleifera Extract: Preparation, Characterization, and Activity". International Journal of Applied Pharmaceutics. 43-51. 10.22159/ijap.2023v15i4.47709.

[9] W. Syafriah, M. T. Teheni, and I. R. (2023). "Synthesis and Characterization of Silver Nanoparticles from the Leaf Stalk Extract of Moringa oleifera". Indonesian Journal of Chemical Research. 11 (1): 37-42. 10.30598//ijcr.2023.11-irw.

[10] S. A. Nararya. (2015). "Uji Toksisitas Daun Kelor ( Moringa Oleifera) Terhadap Sel Fibroblas Gingiva Menggunakan Uji MTT Assay". Jurnal Biosains Pascasarjana. 17 (1). 10.20473/jbp.v17i1.2015.52-58.

[11] N. Gupta, R. Gupta, A. K. Acharya, B. Patthi, V. Goud, S. Reddy, A. Garg, and A. Singla. (2016). "Changing Trends in oral cancer - a global scenario". Nepal Journal of Epidemiology. 6 (4): 613-619. 10.3126/nje.v6i4.17255.

[12] I. G. A. Y. U. Artini. (2014). "Cancer in the Era of Targeting Therapy". Indonesian Journal of Cancer. 7 (3): 111-117.

[13] Z. Shi, N. Dragin, M. L. Miller, K. F. Stringer, E. Johansson, J. Chen, S. Uno, F. J. Gonzalez, C. A. Rubio, and D. W. Nebert. (2010). "Oral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype". International Journal of Cancer. 127 (10): 2334-50. 10.1002/ijc.25222.

[14] B. Neville, D. Damm, C. Allen, and A. Chi. (2016). "Oral and maxillofacial pathology". Elsevier, St. Louis.

[15] S. H. Huang and B. O'Sullivan. (2013). "Oral cancer: Current role of radiotherapy and chemotherapy". Medicina oral, patologia oral y cirugia bucal. 18 (2): e233-40. 10.4317/medoral.18772.

[16] A. Pearce, M. Haas, R. Viney, S. A. Pearson, P. Haywood, C. Brown, and R. Ward. (2017). "Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study". PLoS One. 12 (10): e0184360. 10.1371/journal.pone.0184360.

[17] A. Leone, A. Spada, A. Battezzati, A. Schiraldi, J. Aristil, and S. Bertoli. (2015). "Cultivation, Genetic, Ethnopharmacology, Phytochemistry and Pharmacology of Moringa oleifera Leaves: An Overview". International Journal of Molecular Sciences. 16 (6): 12791-835. 10.3390/ijms160612791.

[18] B. Clevenger and T. Richards. (2015). "Pre-operative anaemia". Anaesthesia. 70 Suppl 1 : 20-8. 10.1111/anae.12918.

[19] M. Esquivel-Velazquez, P. Ostoa-Saloma, M. I. Palacios-Arreola, K. E. Nava-Castro, J. I. Castro, and J. Morales-Montor. (2015). "The role of cytokines in breast cancer development and progression". Journal of Interferon & Cytokine Research. 35 (1): 1-16. 10.1089/jir.2014.0026.

[20] X. Wang, M. Chen, J. Zhou, and X. Zhang. (2014). "HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review)". International Journal of Oncology. 45 (1): 18-30. 10.3892/ijo.2014.2399.

[21] A. Inggriani and P. Husni. (2016). "artikel review: Formulasi nanopartikel untuk terapi kanker". Farmaka. 14 (1): 127-135.

[22] V. Mamillapalli, A. M. Atmakuri, and P. Khantamneni. (2016). "Nanoparticles for Herbal Extracts". Asian Journal of Pharmaceutics. 2016 (2): 54-60.

Downloads

Published

2023-11-22

How to Cite

[1]
T. I. Budhy, “The Potential of Moringa Leaf Nanoparticles (Moringa oleifera) on the Expression of TNFα, IL10, and HSP 27 in Oral Cavity Cancer”, J. Multidiscip. Appl. Nat. Sci., vol. 4, no. 1, pp. 120-129, Nov. 2023.

Issue

Vol. 4 No. 1 (2024): Journal of Multidisciplinary Applied Natural Science

Section

Articles

License

Copyright (c) 2023 Theresia Indah Budhy, Deddy Adam, Zulikran Moh Rizki Azis, Vania Syahputri, M Gandul Atik Yuliani, Muhammad Febriano Sugiarso Suwarto, Fery Setiawan

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:
  1. Authors retain copyright and acknowledge that the Journal of Multidisciplinary Applied Natural Science is the first publisher, licensed under a Creative Commons Attribution 4.0 International License.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges and earlier and greater citation of published work.